focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.575
Bid: 0.55
Ask: 0.60
Change: 0.005 (0.88%)
Spread: 0.05 (9.091%)
Open: 0.57
High: 0.00
Low: 0.00
Prev. Close: 0.57
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Quiz sales fall, names new CEO; Byotrol eyes AIM exit

Wed, 03rd Apr 2024 10:59

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Quiz PLC - Glasgow, Scotland-based fashion retailer - Chief Executive Officer Tarak Ramzan, who also founded Quiz and is largest shareholder, steps down from post. He takes on a non-executive director role. Chief Commercial Officer Sheraz Ramzan takes over as CEO immediately. "He will implement a turnaround strategy to recalibrate the Quiz brand, its product offering, and reconnect with consumers with the aim of moving the business back into profitable growth," the firm says. Non-Executive Chair Peter Cowgill to take a "more active role in supporting the Company through to conclusion of the ongoing review of strategic options". Cowgill was formerly executive chair of JD Sports Fashion PLC. Quiz adds: "In addition to these changes, the board continues to search for at least one additional independent non-executive director following Charlotte O'Sullivan's departure in November 2023 and will provide an update in due course." Quiz says UK sales continue to be "impacted by subdued levels of traffic both in-store and online". Between the start of 2024 up to February 29, sales fell 9% on-year to GBP8.6 million. Sales since the start of the financial year on April 1 until the end of February fell 12% annually to GBP74.4 million. Expects revenue and a pretax loss in line with expectations. Quiz adds: "The group is taking a number of positive steps to counter the impact of the declining revenues including targeting cost savings for the forthcoming year, eliminating loss making activities, reviewing operational efficiencies and optimising its product offer."

----------

Byotrol PLC - manufacturer of biocidal and antimicrobial cleaning products - Proposes cancellation of AIM listing and re-registration as private company, as its directors conclude that it is no longer financially viable to continue trading shares publicly. In a trading update, Byotrol says it expects product sales in the financial year ending Sunday to be in line with expectations at GBP3.9 million, up 5.4% from GBP3.7 million a year earlier on a like-for-like basis, excluding discontinued items. It now expects headline loss before interest, tax, depreciation and amortisation, before exceptionals, of GBP1.0 million, widening from GBP700,000 a year earlier.

----------

Molecular Energies PLC - North, Central and South America-focused oil and gas company - Proposes cancelling its listing on AIM in London, saying it can no longer justify the "disproportionately high costs"."I take no joy in recommending the cancellation of trading in Molecular's shares on AIM and know that this proposal will impact many shareholders. However, the primary benefits of being listed are to avail oneself of access to capital, the ability to utilise one's shares as currency and enjoying the reputational boost of being on the London Stock Exchange. Molecular no longer receives any of those benefits," says Chair Peter Levine. "As a group its interests are best served by turning to the private arena where Molecular can regenerate away from the microscope and constraints of the public markets yet avail itself of funding and exit opportunities in some ways more flexible and abundant than remaining as a small public company on the London market." Reconsiders merit of float of 75% owned carbon removal and mitigation subsidiary Green House Capital Group PLC but believes the IPO is not in the "best interests of the company or its shareholders at the current time". Shareholders to vote on Molecular's delisting proposal on April 15. The last day of dealings could be April 26.

----------

Hellenic Dynamics PLC - Cultivator and supplier of medical cannabis products with a facility in northern Greece - Riverfort Securities Ltd subscribes for shares in Hellenic in order to discharge part of an outstanding loan to the medical cannabis cultivator. The loan and accrued interest of GBP90,757 will be settled through the issue of 3.9 million shares at 2.34 pence each.

----------

Provexis PLC - Reading, England-based producer of heart-health functional food ingredient Fruitflow - Agrees purchase of further batch of Fruitflow II SD inventory from dsm-firmenich, to satisfy increasing demand. Purchase totals GBP341,000. Provexis issues 45.1 million new shares, worth GBP293,304, to dsm-firmenich to part satisfy purchase. Rest of consideration to be satisfied in cash. "The Company is also pleased to confirm that it has now completed the setup of a new Irish subsidiary company, Provexis Ireland Ltd, which will facilitate tariff free sales of Fruitflow to customers in the EU," Provexis adds.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based drug discovery and development company - Says in advanced talks with "various investors in order to secure immediate funding". "The company's current cash balance is sufficient to allow the Faron to continue its operations into April 2024, however whilst the company is in advanced negotiations to complete the remaining bridge financing of approximately EUR5 million shortly, the Company notes that there is no guarantee that the required funds will be raised," Faron adds.

----------

Real Estate Credit Investments Ltd - investor in European real estate credit markets - Plans further buyback programme which runs to September 30 worth GBP10.0 million in total. Initial buyback of GBP5.0 million had expired at end of March.

----------

Coro Energy PLC - South East Asian-focused energy company - Notes announcement from Conrad Asia Energy Ltd, holder of 77% interest in Duyung production sharing contract in offshore Indonesia. Conrad announces gas sales agreement for domestic portion of Mako gas to Indonesia's national oil company PT Pertamina. Coro has a 15% stake in the production sharing pact. Empyrean Energy PLC, with an 8.5% interest, also notes the announcement. Both also note a new reserves report for Duyung. Revised estimate of best case recoverable dry gas as of December 31 stands at 329 billion cubic feet. This is a 10% decrease from a July 2022 report.

----------

San Leon Energy PLC - Nigeria-focused oil and gas production, development and exploration company - Notes Decklar Petroleum Ltd announces Crude oil volumes from Oza field through Trans Niger pipeline to Bonny export terminal. Just over 18,400 barrels of crude oil transported so far in 2024. "Decklar and Millenium have injected a total of 34,600 barrels of crude oil into the Bonny Export Terminal from commencement of TNP pipeline operation in late 2023," San Leon adds. It has an 11% shareholding in Decklar.

----------

Global Connectivity PLC - Isle of Man-based broadband provider to rural areas in the UK - Changes terms of warrants attached to shares subscribed for at time of initial public offering back in October 2020. Extends warrant exercise period by two years to April 20, 2026 for 100.0 million investor warrants and cuts exercise price to 1.5p per share. For 1.6 million adviser warrants, which had been due to expire in October 2025, the exercise period is also extended to April 2026 and also at 1.5p per share. Executive Chair Keith Harris says: "In recognition of the support offered to us by investors and other stakeholders at the stage of our initial listing, your board has decided to improve the terms of the warrants issued at that time as described above. We continue to explore other potential investments in companies in the communication services space and technologies that enhance connectivity."

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
5 Aug 2012 14:10

Sunday share tips: GKN, Provexis, BP

First-half numbers from specialist engineer GKN beat market expectations, with pre-tax profits leaping 43 per cent. Nigel Stein, chief executive, also gave some upbeat interviews, indicating that, while many of GKN's customers were cautious about the rest of 2012, "no one is pressing alarm buttons"

Read more
31 Jul 2012 11:51

Small caps: IndigoVision, Silence Therapeutics, Air Partner...

Air Partner, a provider of air charter services, has said underlying profit before tax for the year is expected to meet its forecasts. The firm's cost reduction programme is also now nearly complete and will realise 'significant cost savings' in the next financial year, with a one off restructuring

Read more
14 Feb 2012 10:12

Small caps round-up: Provexis, CareTech, Nanoco ...

Sports nutrition specialist Provexis said an industrial scale production of Fruitflow powder, was successfully completed in 2012. Fruitflow is Provexis's tomato extract which inhibits platelet aggregating and therefore reduces the chance of heart disease. Provexis has identified a potential applic

Read more
15 Dec 2011 15:01

Sector movers: Old Mutual boosts life insurers after Nordic sale

Life insurance stocks were on the rise on Thursday afternoon, helped by FTSE 100 savings, investment and insurance group Old Mutual. Shares in Old Mutual roared higher on Thursday after announcing that it is to sell its Nordic business Skandia AB for £2.1bn in an effort to "reduce complexity" and p

Read more
1 Dec 2011 12:40

First half losses grow at Provexis

Medical food and dietary supplement developer Provexis disappointed investors with widened losses for the six months ended 30 September. The share price fell 23.08% to 1.75p by 13:05. The losses, which grew from £1m to £1.5m, came despite revenues doubling from £0.7m to £1.5m after costs rose signi

Read more
17 Jun 2011 09:20

Provexis hurt by R&D costs, acquisition fails to inspire

Medical food and dietary supplement developer Provexis reported a wider pre-tax loss, hurt by increased research and development expenses, while its plans to acquire a sports nutrition products manufacturer failed to inspire investors. For the year ended March 31, Provexis posted a loss before tax

Read more
16 Dec 2010 07:49

Rising R&D costs hurt Provexis

Medical food and dietary supplement developer Provexis said pre-tax losses almost doubled as it increased research and development spending. Investment in R&D increased to £612,171 in the period, up from £289,125 in the same period last year, as the group broadens its product pipeline. The group

Read more
9 Sep 2010 16:23

Provexis to exhibit Fruitflow later this year

The board of functional and medical food company Provexis has set itself the task in the coming year of maximising the commercial opportunity for Fruitflow, its patented tomato extract which aims to improve heart health. The marketing strategy for Fruitflow is now being finalised and the technology

Read more
26 Jul 2010 16:55

Provexis widens Fruitflow approvals

Functional foods developer Provexis has gained approval from the European Food Safety Authority (EFSA) to use its Fruitflow technology in dietary supplements. Fruitflow was already allowed to be used in drinks by the EFSA. Provexis can also use the claim that Fruitflow "helps maintain normal plate

Read more
26 Jul 2010 07:33

Provexis: Fruitflow Gets Further European Food Safety Approval

LONDON (Dow Jones)--Provexis PLC (PXS.LN), a company which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, Monday announces a widening of the European Food Safety Authority (EFSA) opinion on the Company's

Read more
22 Jun 2010 07:33

Provexis Raises GBP88,869 In Draw Down Of Funds, Equity Issue

LONDON (Dow Jones)--Provexis PLC (PXS.LN), which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, said Tuesday it has raised net proceeds of GBP88,869 by drawing down on its Equity Financing Facility with

Read more
31 Mar 2010 17:07

London close: Up and down day for London

The movements of the blue-chip index looked like they were being directed by the grand old Duke of York on Wednesday, with the market finishing neither up nor down. British Sky Broadcasting (BSkyB) was predictably outraged at the decision by telecoms regulator Ofcom to order it to make its two top

Read more
31 Mar 2010 16:08

Small caps round-up: Provexis, Renew, Source BioSciences...........

Functional foods developer Provexis expects to have net cash of £7m at the end of March 2010. It has also entered into a three-year, £25m equity financing facility provided by Evolution Securities through its subsidiary Darwin Strategic. This could be used to help finance acquisitions. Renew Holdi

Read more
9 Mar 2010 08:45

Provexis surges on test results

Shares in medical food and dietary supplement developer Provexis shot up on Tuesday after it published the results of a trial of its Fruitflow product, which is designed to reduce the risk of heart attack, stroke and venous thrombosis. Fruitflow, a tomato extract which counters unwanted clot forma

Read more
17 Dec 2009 12:03

Small cap round-up: ILX, Ideal Shopping, Provexis...

E-learning company ILX has won three contracts that are expected to produce revenues of more than £0.27m over the life of the contracts. The first contract is to provide project management training to a major government department over a period of three years. The other two contracts are for overse

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.